UPDATE: Canaccord Genuity Starts IRIS International (IRIS) at Buy; Leader of Urinalysis Diagnostics Systems
Tweet
Share
E-mailGet Alerts IRIS Hot Sheet
Price: $19.49 --0%
Rating Summary:
1 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
1 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
(Updated - August 29, 2012 8:46 AM EDT)
Canaccord Genuity initiates coverage on IRIS International (NASDAQ: IRIS) with a Buy. PT $14.00.
Analyst, Jeffrey Frelick, said, "IRIS is the worldwide leader of urinalysis diagnostics systems and is expanding into higher-value hematology, molecular diagnostics and personalized medicine, a $2B+ opportunity."
For an analyst ratings summary and ratings history on IRIS International click here. For more ratings news on IRIS International click here.
Shares of IRIS International closed at $12.55 yesterday.
Canaccord Genuity initiates coverage on IRIS International (NASDAQ: IRIS) with a Buy. PT $14.00.
Analyst, Jeffrey Frelick, said, "IRIS is the worldwide leader of urinalysis diagnostics systems and is expanding into higher-value hematology, molecular diagnostics and personalized medicine, a $2B+ opportunity."
For an analyst ratings summary and ratings history on IRIS International click here. For more ratings news on IRIS International click here.
Shares of IRIS International closed at $12.55 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Starts Everus (ECG) at Buy
- TD Cowen Assumes Sana Biotechnology (SANA) at Buy
- Keefe, Bruyette & Woods Resumes Canadian Imperial Bank of Commerce (CM:CN) (CM) at Market Perform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
